Summary of Significant Accounting Policies - Narrative (Details) shares in Thousands |
12 Months Ended | |
|---|---|---|
|
Jun. 30, 2025
USD ($)
lease
region
shares
|
Jun. 30, 2024
USD ($)
shares
|
|
| Summary of Significant Accounting Policies Additional Information [Abstract] | ||
| Recorded bad debt expense | $ 0 | $ 0 |
| Reduction in inventory | 500,000 | 1,300,000 |
| Impairment of intangible assets | 0 | 0 |
| Research and development | $ 1,400,000 | $ 700,000 |
| Number of finance leases | lease | 0 | |
| Number of antidilutive securities (in shares) | shares | 30 | 13 |
| Number of geographic segments | region | 2 | |
| Cash Accounts Held Primarily At Financial Institution | ||
| Summary of Significant Accounting Policies Additional Information [Abstract] | ||
| Concentration of credit risk | $ 17,000,000.0 | |
| Cash Accounts Held at Other Financial Institutions | ||
| Summary of Significant Accounting Policies Additional Information [Abstract] | ||
| Concentration of credit risk | $ 3,200,000 | |
| X | ||||||||||
- Definition Number of Finance Leases No definition available.
|
| X | ||||||||||
- Definition Number of geographic segments. No definition available.
|
| X | ||||||||||
- Definition Summary of significant accounting policies. No definition available.
|
| X | ||||||||||
- Definition Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Maximum amount of loss due to credit risk that, based on the gross fair value of the financial instrument, the entity would incur if parties to the financial instruments that make up the concentration failed completely to perform according to the terms of the contracts and the collateral or other security, if any, for the amount due proved to be of no value to the entity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of inventory reserves for last-in first-out (LIFO) and other inventory valuation methods. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of expense (reversal of expense) for expected credit loss on accounts receivable. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|